For the past 20 to 25 years, data has shown that half of patients prescribed long-term medications do not take them as prescribed.
In part 5 of this Frontline Forum, Raj Chovatiya, MD, PhD; Neal D. Bhatia, MD; Alexandra K. Golant, MD; and Brett King, MD, PhD, discuss the rapidly changing use for JAK inhibitors and other agents for atopic dermatitis.
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.
A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.
Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.
Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
A real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.
Pulsed dye lasers are now being used for several different dermatologic conditions.
There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
A variety of topicals and biologics are now available to treat children affected by this challenging condition.
What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
There are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.
More research is needed to understand the pathogenesis underlying this association.
Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Payers must make public the individual amounts their health plans pay providers across all types of services and locations, including hospitals, doctors’ offices, imaging centers, outpatient surgery centers and urgent care clinics.
New pathways of care are needed to improve health care spending.
Will Kirby, DO, FAOCD, talks with Dustin Portela, DO, FAAD, about TikTok, what being a KOL really means, and the biggest aesthetic myth in the industry right now.
Hiring investigators of color, educating and building trust with potential participants, and addressing funding can make clinical trials more diverse.
The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.
Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
Results from the test reveal that high levels of the immune biomarker Thymus and Activation-Regulated Chemokine (TARC) in babies increases their chances of developing atopic dermatitis.
Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.
Defining the goals of the mentoring relationship can be useful to clarify expectations.
The topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.